| Literature DB >> 26261484 |
Jun Zhou1, Dandan Zhang1, Guiming Hu1, Xiangyu Zheng1, Qin Shen2, Wencai Li1, Gannan Wang1, Yihui Ma1, Jingjing Xu1, Zhihua Zhao1.
Abstract
Sclerosing angiomatoid nodular transformation (SANT) of spleen is a benign lesion with a distinct morphological and immunohisochemical characteristics. Only Weinred I et al (Virchow Arch 451: 73-9, 2007) reported 6 cases of SANT expressing CD30, of which positive for EBV by in situ hybridization (EBER). 4 cases of SANT were added to investigate the clinicopathological features and focused on the expression of CD30 and EBER combined with the previously published literature. Histologically, individual angiomatoid nodules were sharply delineated by fibrocollagenous stroma with numerous vascular lumens and surrounded by a different population of spindle and ovoid cells. Angiomatoid nodules of all of the 4 cases heterogeneously expressed CD34, CD8, CD68 and diffusely demonstrated CD31 and CD30, but none were positive for EBER. We added these cases with reviewed literature to emphasize and verify the fact that upregulated expression of CD30 in SANT is quite common, which should be taken into consideration when making differential diagnosis.Entities:
Keywords: CD30; EBER; Spleen; differential diagnosis; sclerosing angiomatoid nodular transformation
Mesh:
Substances:
Year: 2015 PMID: 26261484 PMCID: PMC4525818
Source DB: PubMed Journal: Int J Clin Exp Pathol ISSN: 1936-2625